COVID-19 CLINICAL TRIAL SITES
Refer to this map to locate a clinical trial site near you that is currently participating in Humanigen's Phase 3 study of lenzilumab™ in patients with COVID-19.
For more information regarding this trial, visit StopStorm.com, visit ClinicalTrials.gov (Identifier: NCT04351152), or contact:
CTI Clinical Trial & Consulting Services (CRO)
1-800-732-4126